Biotech Investors & VC Firms in New York

141 firms in this list, with a median first check of $500K. 31 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
NYU Innovation Venture Fund 33 people	New York	US	Pre-Seed–Series A	$100K – $500K	+ Add to CRM
Digitalis Ventures 15 people · Leads rounds	New York	US	Seed–Late Stage	$100K – $10M	+ Add to CRM
Argonautic Ventures 9 people · Leads rounds	New York	US	Pre-Seed–Growth	$5M	+ Add to CRM
Emles Venture Partners 14 people · Follows rounds	New York	US	Pre-Seed–Seed	—	+ Add to CRM
Blackstone Life Sciences 30 people	New York	US	Series A–Late Stage	$20M – $60M	+ Add to CRM
Black Opal Ventures 28 people	New York	US	Seed–Late Stage	—	+ Add to CRM
Lever VC 17 people · Leads rounds	New York	US	Pre-Seed–Series A	$100K – $5M	+ Add to CRM
Signet Healthcare Partners 13 people · Leads rounds	New York	US	Growth–Late Stage	$10M – $50M	+ Add to CRM
Windham Capital Partners 17 people · Leads rounds	New York	US	Series A–Growth	$1M – $5M	+ Add to CRM
AIN Ventures 14 people · Follows rounds	New York	US	Pre-Seed–Series A	$500K – $1M	+ Add to CRM
Forepont Capital Partners 26 people · Leads rounds	New York	US	Pre-Seed–Late Stage	—	+ Add to CRM
Essex Woodlands Healthcare Partners 18 people · Leads rounds	New York	US	Growth–Late Stage	$20M – $80M	+ Add to CRM
Able Partners 3 people · Follows rounds	New York	US	Pre-Seed–Series A	$500K – $3M	+ Add to CRM
Oberland Capital 20 people	New York	US	Growth–Late Stage	$50M – $300M	+ Add to CRM
Adjuvant Capital 19 people	New York	US	Series A–Late Stage	$10M – $25M	+ Add to CRM
AtaiBeckley 26 people · Follows rounds	New York	US	—	—	+ Add to CRM
Medical Excellence Capital 21 people · Follows rounds	New York	US	Pre-Seed–Series B	—	+ Add to CRM
Plum Alley Investments 15 people · Follows rounds	New York	US	Pre-Seed–Series A	$500K – $1.5M	+ Add to CRM
Social Impact Capital 20 people · Follows rounds	New York	US	Pre-Seed–Series A	$100K – $1.5M	+ Add to CRM
Owl Rock Capital 20 people · Leads rounds	New York	US	Growth–Late Stage	$20M – $250M	+ Add to CRM
Oncology Ventures 17 people	New York	US	Seed–Series B	—	+ Add to CRM
BIOSPRING PARTNERS 22 people	New York	US	Growth–Late Stage	—	+ Add to CRM
New Mountain Capital 6 people	New York	US	Growth–Late Stage	—	+ Add to CRM
Redesign Health 18 people	New York	US	Seed–Late Stage	—	+ Add to CRM